How does PAOG's PB Ratio compare to its peers?

Insufficient data to calculate PAOG's Price-To-Book Ratio vs. peers for valuation analysis.

How does PAOG's PB Ratio compare vs other companies in the US Pharmaceuticals Industry?

Insufficient data to calculate PAOG's Price-To-Book Ratio vs. industry for valuation analysis.

What is PAOG's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

Insufficient data to calculate PAOG's Price-To-Book Fair Ratio for valuation analysis.

What is the Fair Price of PAOG when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Insufficient data to calculate PAOG's fair value for valuation analysis.

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Insufficient data to show price forecast.

PAO Group (OTCPK:PAOG) - Stock Price, News & Analysis

PAOG Stock Overview

Focuses on alternative patient care treatments. More details

PAOG fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Has not reported any financial data

Does not have a meaningful market cap ($573K)

Highly volatile share price over the past 3 months compared to the US market

PAO Group, Inc. Competitors

AmeriCann

OTCPK:ACAN

US$465.9k

Kid Castle Educational

OTCPK:KDCE

US$357.2k

SciSparc

NasdaqCM:SPRC

US$768.3k

TFF Pharmaceuticals

NasdaqCM:TFFP

US$1.5m

Price History & Performance

Summary of all time highs, changes and price drops for PAO Group
Historical stock prices
Current Share Price	US$0.0003
52 Week High	US$0.0033
52 Week Low	US$0.0003
Beta	0
11 Month Change	-25.00%
3 Month Change	-25.00%
1 Year Change	-57.14%
33 Year Change	-90.00%
5 Year Change	-33.33%
Change since IPO	-100.00%

Recent updates

Shareholder Returns

	PAOG	US Pharmaceuticals	US Market
7D	0%	2.6%	0.5%
1Y	-57.1%	13.1%	30.7%

Return vs Industry: PAOG underperformed the US Pharmaceuticals industry which returned 14.2% over the past year.

Return vs Market: PAOG underperformed the US Market which returned 32.3% over the past year.

Price Volatility

Is PAOG's price volatile compared to industry and market?
PAOG volatility
PAOG Average Weekly Movement	31.0%
Pharmaceuticals Industry Average Movement	9.9%
Market Average Movement	6.3%
10% most volatile stocks in US Market	16.3%
10% least volatile stocks in US Market	3.1%

Stable Share Price: PAOG's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: PAOG's weekly volatility (31%) has been stable over the past year, but is still higher than 75% of US stocks.

About the Company

Founded	Employees	CEO	Website
n/a	n/a	Jim DiPrima	www.pao.group

PAO Group, Inc. focuses on alternative patient care treatments. The company, through its subsidiaries, engages in the development, sale, and distribution of premium medical cannabis products for treatment of chronic and terminal patients. The company is headquartered in Sandusky, Ohio.

PAO Group, Inc. Fundamentals Summary

How do PAO Group's earnings and revenue compare to its market cap?
PAOG fundamental statistics
Market cap	US$573.06k
Earnings (TTM)	US$0
Revenue (TTM)	n/a

n/a

P/E Ratio

n/a

P/S Ratio

Is PAOG overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
PAOG income statement (TTM)
Revenue	US$0
Cost of Revenue	US$0
Gross Profit	US$0
Other Expenses	US$0
Earnings	US$0

Last Reported Earnings

n/a

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did PAOG perform over the long term?

See historical performance and comparison

PAO Group OTCPK:PAOG Stock Report